Replimune (REPL) Receivables - Other (2018 - 2026)
Replimune (REPL) recorded Receivables - Other of $1.62 million in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 56.5% from $3.73 million a year earlier and down 45.2% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Receivables - Other (2018 - 2026) Analysis & Trends
Starting with fiscal Q4 2018, Replimune's Receivables - Other history includes 33 quarters.
- Annual Receivables - Other has a five-year compound annual growth rate of -11.3% (FY2021 to FY2026).
- Across earlier fiscal years, Receivables - Other came in at $3.73 million in FY2025 (-24.3%), $4.92 million in FY2024 (+67.5%), $2.94 million in FY2023 (-5.2%) and $3.1 million in FY2022 (+5.0%).
- The fiscal Q4 2026 figure is the lowest quarterly Receivables - Other in data going back to fiscal Q4 2018.
- On a year-over-year basis, Receivables - Other has declined for seven consecutive quarters, with an average decline of 19.4% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 115.2% in fiscal Q3 2024, against a decline of 62.6% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $2.96 million (Q3 2026), $1.81 million (Q2 2026) and $1.84 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 2.94 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | 2.21 Mn |
| Sep 30, 2021 | 2.89 Mn |
| Jun 30, 2021 | 2.97 Mn |
API Access
Replimune Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();